Completed PHASE3 NCT00501137

A Controlled Trial to Assess the Immunogenicity of a Proposed Paediatric Dosing Schedule of Human Papillomavirus Vaccine

Sponsor: Ministry of Health, British Columbia

Conditions Cervical Cancer Genital Warts

Interventions HPV (Human Papillomavirus) Vaccine

Updated 5 times since 2017 Last updated: Apr 8, 2015 Started: Jul 31, 2007 Primary completion: Feb 29, 2008 Completion: Dec 31, 2010

Listed as NCT00501137, this PHASE3 trial focuses on Cervical Cancer and Genital Warts and remains completed. Sponsored by Ministry of Health, British Columbia, it has been updated 5 times since 2007, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Jul 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ministry of Health, British Columbia
Simon Dobson

Data source: University of British Columbia

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Vancouver, Canada